Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H30O4 |
Molecular Weight | 346.4605 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](O)[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CCC4=CC(=O)CC[C@]34C
InChI
InChIKey=CXDWHYOBSJTRJU-SRWWVFQWSA-N
InChI=1S/C21H30O4/c1-12(22)21(25)18(24)11-17-15-5-4-13-10-14(23)6-8-19(13,2)16(15)7-9-20(17,21)3/h10,15-18,24-25H,4-9,11H2,1-3H3/t15-,16+,17+,18-,19+,20+,21-/m1/s1
Molecular Formula | C21H30O4 |
Molecular Weight | 346.4605 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Algestone is a progesterone like female hormone. Algestone is a C21-steroid that is pregn-4-ene substituted by oxo groups at position 3 and 20 and hydroxy groups at positions 16 and 17. It has a role as a progestin. It is a 20-oxo steroid, a 16alpha-hydroxy steroid, a 17-hydroxy steroid, a C21-steroid, a 3-oxo-Delta(4) steroid and a tertiary alpha-hydroxy ketone. It derives from a hydride of a pregnane. Algestone is used as anti-inflammatory drug (topical) and combination with enanthate as injectable contraceptive.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P08185 Gene ID: 866.0 Gene Symbol: SERPINA6 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/8474098 |
6.247 null [pKd] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:12:32 GMT 2023
by
admin
on
Fri Dec 15 17:12:32 GMT 2023
|
Record UNII |
3JEB53B3WT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB05321MIG
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
209-869-2
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
C166678
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105960
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
1819
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
3JEB53B3WT
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
DTXSID40208200
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
m1502
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | Merck Index | ||
|
595
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | RxNorm | ||
|
Algestone
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
595-77-7
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
763
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
11687
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY | |||
|
100000087877
Created by
admin on Fri Dec 15 17:12:32 GMT 2023 , Edited by admin on Fri Dec 15 17:12:32 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |